AWM
GSK icon

Arbor Wealth Management’s GSK GSK Stock Holding History

Arbor Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-95
Closed -$5K – 109
2019
Q2 		$5K Sell
95
-96
-50% -$4.82K ﹤0.01% 170
2019
Q1 		$10K Hold
191
– – 0.01% 132
2018
Q4 		$9K Buy
+191
New +$9.41K 0.01% 119
2018
Q1 		– Sell
-7,257
Closed -$321K – 66
2017
Q4 		$321K Sell
7,257
-423
-6% -$19.5K 0.24% 58
2017
Q3 		$335K Sell
7,680
-954
-11% -$48.4K 0.29% 56
2017
Q2 		$418K Sell
8,634
-454
-5% -$24.2K 0.4% 44
2017
Q1 		$491K Sell
9,088
-309
-3% -$15.7K 0.43% 48
2016
Q4 		$473 Buy
9,397
+216
+2% +$10.7K 0.37% 51
2016
Q3 		$489K Sell
9,181
-259
-3% -$14.2K 0.42% 52
2016
Q2 		$534K Buy
9,440
+514
+6% +$27.1K 0.5% 44
2016
Q1 		$477K Buy
8,926
+274
+3% +$13.6K 0.49% 46
2015
Q4 		$425K Buy
+8,652
New +$441K 0.46% 58

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arbor Wealth Management's GSK Position: Q3 2019 in Review

Arbor Wealth Management sold out of GSK (GSK) in Q3 2019, closing a stake of 95 shares — an estimated $5K sold.

Arbor Wealth Management first reported a position in GSK in Q4 2015 and held it in 12 quarters. The position peaked at $534K in Q2 2016. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Arbor Wealth Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Arbor Wealth Management sold 95 GSK shares in Q3 2019, an estimated $5K.
  • Arbor Wealth Management first reported a position in GSK in Q4 2015 and held it in 12 quarters.
  • Arbor Wealth Management's GSK position peaked at $534K in Q2 2016.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Arbor Wealth Management's 13F filing for Q3 2019, filed 6 Nov 2019.